Alternatives to antibiotics—a pipeline portfolio review
Lloyd G. Czaplewski(University of Kent), Richard Bax, Martha R. J. Clokie(University of Leicester), Mike Dawson(Hertfordshire Community NHS Trust), Heather Fairhead, Vincent A. Fischetti(Rockefeller University), Simon J. Foster(Absynth Biologics (United Kingdom)), Brendan Gilmore(Queen's University Belfast), Robert E. W. Hancock(University of British Columbia), David J. Harper(University of Bedfordshire), Ian R. Henderson(University of Birmingham), Kai Hilpert(St George's, University of London), Brian V. Jones(Queen Victoria Hospital NHS Foundation Trust), Aras Kadioglu(University of Liverpool), DAVID J. C. KNOWLES(Procarta Biosystems (United Kingdom)), Sigríður Ólafsdóttir(Icelandic Meteorological Office), David Payne(GlaxoSmithKline (United States)), Steve Projan, Sunil Shaunak(Imperial College London), Jared Silverman, Christopher M. Thomas(The Edgbaston Hospital), T J Trust(Pan-Provincial Vaccine Enterprise), Peter Warn(Evotec (United Kingdom)), John Rex(AstraZeneca (Brazil))
Cited by 841Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis